search
Back to results

Efficacy of Integrated Therapy of rTMS and rPMS on Upper Limb Function in Patients With Stroke

Primary Purpose

Stroke

Status
Unknown status
Phase
Not Applicable
Locations
Taiwan
Study Type
Interventional
Intervention
rTMS+rPMS_iTBS_R
rTMS+rPMS_cTBS_R
rTMS +sham-rPMS
rTMS+rPMS_iTBS_M/U
rTMS+rPMS_cTBS_M/U
sham-rTMS+sham-rPMS
rTMS + optimal-rPMS
sham-rTMS+optimal-rPMS
Sponsored by
Chang Gung Memorial Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Stroke focused on measuring Repetitive transcranial magnetic stimulation, Repetitive peripheral magnetic stimulation, stroke, novel treatment

Eligibility Criteria

20 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • first stoke and in stable phase
  • age 20-80 years
  • unilateral brain lesions with unilateral hemiplegia
  • brain wave examination without epileptic waves

Exclusion Criteria:

  • brain stem or cerebellar stroke
  • Patients with epilepsy
  • Patients with aneurysm or cerebrovascular malformation
  • Patients with mental illness
  • Patients with degenerative diseases (such as neurodegenerative diseases)
  • Patients with severe intelligence or language barriers (such as mental retardation or severe communication impairment)
  • Patients with serious medical conditions (such as heart failure)
  • Patients with acute disease (such as infection)
  • Patients had metal implants in the body (such as cardiac rhythm or brain metal implants, metal clips for aneurysms)
  • Patients had botox injection or surgery in the first half of the study
  • pregnant woman or breastfeeding woman
  • other obstacles (such as claustrophobia, obesity, etc.)

Sites / Locations

  • Chang Gung Memoria HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm 5

Arm 6

Arm 7

Arm 8

Arm 9

Arm Type

Experimental

Experimental

Sham Comparator

Experimental

Experimental

Sham Comparator

Experimental

Experimental

Sham Comparator

Arm Label

rTMS+rPMS_iTBS_R

rTMS+rPMS_cTBS_R

rTMS +sham-rPMS

rTMS+rPMS_iTBS_M/U

rTMS+rPMS_cTBS_M/U

sham-rTMS+sham-rPMS

rTMS + optimal-rPMS

rTMS+ sham-rPMS

sham-rTMS+optimal-rPMS

Arm Description

In this group, they received intermittent theta burst stimulation(iTBS) on affected hemisphere after following iTBS at radial nerve on affected hand.

In this group, they received intermittent theta burst stimulation on affected hemisphere after following continuous theta burst stimulation(cTBS) at radial nerve on affected hand.

In this group, they received iTBS on affected hemisphere after following sham TBS stimulation at radial nerve on affected hand.

In this group, they received iTBS on affected hemisphere after following iTBS at median/ulnar nerve on affected hand.

In this group, they received iTBS on affected hemisphere after following cTBS at median/ulnar nerve on affected hand.

In this group, they received iTBS on affected hemisphere after following sham TBS stimulation at median/ulnar nerve on affected hand.

In this group, patient received iTBS on affected hemisphere after following optimal repetitive peripheral magnetic stimulation(rPMS) on affected hand.

In this group, patient received iTBS on affected hemisphere after following sham repetitive peripheral magnetic stimulation on affected hand.

In this group, patient received sham iTBS on affected hemisphere after following optimal repetitive peripheral magnetic stimulation on affected hand.

Outcomes

Primary Outcome Measures

Change from baseline Motion analysis at after six weeks of treatment and three month
All participants will be instructed to perform a series of upper-extremity tasks. The tasks include reaching and grasping. An 7-camera motion analysis system (Vicon system, 3-D Oxfort Metrics Ltd, Oxford, UK) is used in conjunction with a personal computer to capture the movement of markers placed on the participant's body; analog signals were collected simultaneously. Movements were recorded at 120 Hz and digitally low-pass filtered at 5 Hz using a second-order Butterworth filter. Reference markers are placed on the distal interphalangeal joints of the thumb and index finger, the styloid process of the ulna, proximal end of the second metacarpal, and the object.
Change from baseline Motor evoked potential at after six weeks of treatment and three month
The comparison of baseline of Motor Evoked Potential for stroke after different therapy, including resting motor threshold (RMT), active motor thresholds (AMT), input-output curve (IO curve) and stationary period.
Change from baseline Myoton at after six weeks of treatment and three month
The comparison of baseline of Myoton for stroke after different therapy, assessing the functional status of skeletal muscle.
Change from baseline Muscle strength at after six weeks of treatment and three month
The comparison of baseline of Muscle strength for stroke after different therapy, including lateral pinch, palmar pinch, and tip pinch.
Change from baseline Brunnstrom stage at after six weeks of treatment and three month
The Brunnstrom stage is used to classify the severity of stroke patient according to specific movement.
Change from baseline Fugl Meyer Assessment at after six weeks of treatment and three month
The Fugl Meyer Assessment is used to measure upper and lower extremity motor , range of motion, sensation, pain and balance.
Change from baseline Modified Ashworth Scale at after six weeks of treatment and three month
The Modified Ashworth Scale is used to measure the muscle tone of affected limb, for each item minimum value is 0 and maximum value is 4, higher scores mean a worse outcome.

Secondary Outcome Measures

Change from baseline Action Research Arm Test at after six weeks of treatment and three month
The Action Research Arm Test is used to measure bilateral gross manual and finger dexterity.
Change from baseline Box and Block Test at after six weeks of treatment and three month
The Box and Block Test (BBT) measures unilateral gross manual dexterity.
Change from baseline Nine-Hole test at after six weeks of treatment and three month
The Nine-Hole Peg Test (NHPT) is used to measure finger dexterity in patients with various neurological diagnoses.
Change from baseline Jebson Taylor Hand Function Test at after six weeks of treatment and three month
The Jebson Taylor Hand Function Test (JTHFT) is used to assess a broad range of unilateral hand functions required for activities of daily living(ADLs).
Change from baseline Functional Independence Measure at after six weeks of treatment and three month
The purpose of Functional Independence Measure(FIM) is to understand and track adult's life function performance, progress and goal achievement. There are three main areas: self-care, mobility, and cognition. The score is from 1 to 7 points, 1 is completely dependent, and 7 is completely independent.
Change from baseline Motor Activity Log at after six weeks of treatment and three month
The Motor Activity Log(MAL) is used to measure the quality and quantity of a stroke patient when performing activities using the affected hand.
Change from baseline Wolf Motor Function Test at after six weeks of treatment and three month
The Wolf Motor Function Test(WMFT) is used to measure unilateral motor quality and strength.
Change from baseline Nottingham Health Profile at after six weeks of treatment and three month
The Nottingham Health Profile(NHP) is a questionnaire that assesses the quality of life associated with health. There are a total of 38 items, divided into six sub-items: mobility, social isolation, emotional response, pain, sleep and energy.
Change from baseline Stroke Impact Scale at after six weeks of treatment and three month
The Stroke Impact Scale(SIS) is used to measure the influence of several aspects after stroke, for each item minimum value is 1 and maximum value is 5, higher scores mean a better outcome.

Full Information

First Posted
February 2, 2020
Last Updated
March 7, 2022
Sponsor
Chang Gung Memorial Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT04265365
Brief Title
Efficacy of Integrated Therapy of rTMS and rPMS on Upper Limb Function in Patients With Stroke
Official Title
Efficacy of Integrated Therapy of Repetitive Transcranial Magnetic Stimulation and Repetitive Peripheral Magnetic Stimulation on Upper Limb Function in Patients With Stroke
Study Type
Interventional

2. Study Status

Record Verification Date
July 2021
Overall Recruitment Status
Unknown status
Study Start Date
February 27, 2019 (Actual)
Primary Completion Date
December 11, 2022 (Anticipated)
Study Completion Date
February 11, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Chang Gung Memorial Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Repetitive transcranial magnetic stimulation (rTMS) and repetitive peripheral magnetic stimulation (rPMS) are innovative treatments for patients with stroke. Therefore, the integrated therapy of rTMS and with repetitive peripheral magnetic stimulaiton (rPMS) is employed in this project. This proposal aims at exploring different novel treatment strategies in the treatment of UE dysfunction in patients with stroke: rTMS integrated with rPMS.
Detailed Description
Several aims in this study include identifying a better protocol of rPMS with Theta burst stimulation (TBS) and different nerves stimulation location, identifying the most optimal treatment protocols for rPMS (TBS treatment and nerve stimulation location), integrating novel treatment protocol (optimal rTMS + rPMS), comparing efficacy between integrated therapy of optimal rTMS and rPMS treatment and single rTMS or rPMS treatment, determining the mechanism of neuro-motor control, clinical predictors, and related biomarkers for the novel treatment protocol A total of 108-135 patients with stroke will be recruited. During phase 1 (year 1 and year 2), 72 to 90 participants will be randomly enrolled in different groups (12-15 participants in each group). For the first year, the participants will be randomly enrolled in 3 different groups according to the TBS mode (iTBS vs.cTBS). In the second year, the participants will be randomly enrolled in 3 different groups according to the stimulated nerves (radial, median/ulnar nerves) to find the optimal novel treatment protocols for UE dysfunction in patients with stroke. During phase 2 (2-3 years), 36 to 45 patients will be randomly enrolled into 3 groups of rTMS and rPMS integrated therapy to identify optimal integrated novel treatment protocol. Outcome measures include clinical based on International Classification of Functioning, Disability and Health (ICF) and motor control (Motor Evoked Potential, MEP; muscle tone assessment (MYOTON); pinch and grip strength and kinematics of upper extremity) assessments that administered at pretest, posttest, and 3-month follow-up. The aim of this study is to establish the novel assessment and treatment protocols in patients with stroke. The intervention will be conducted 10 times in 2 weeks (five times per week). The optimal effective treatment protocol of combination of rTMS and rPMS will also be established. The results of this study will be applied to the translational and evidence-based medicine of the neuro-rehabilitation field of stroke research.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke
Keywords
Repetitive transcranial magnetic stimulation, Repetitive peripheral magnetic stimulation, stroke, novel treatment

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
90 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
rTMS+rPMS_iTBS_R
Arm Type
Experimental
Arm Description
In this group, they received intermittent theta burst stimulation(iTBS) on affected hemisphere after following iTBS at radial nerve on affected hand.
Arm Title
rTMS+rPMS_cTBS_R
Arm Type
Experimental
Arm Description
In this group, they received intermittent theta burst stimulation on affected hemisphere after following continuous theta burst stimulation(cTBS) at radial nerve on affected hand.
Arm Title
rTMS +sham-rPMS
Arm Type
Sham Comparator
Arm Description
In this group, they received iTBS on affected hemisphere after following sham TBS stimulation at radial nerve on affected hand.
Arm Title
rTMS+rPMS_iTBS_M/U
Arm Type
Experimental
Arm Description
In this group, they received iTBS on affected hemisphere after following iTBS at median/ulnar nerve on affected hand.
Arm Title
rTMS+rPMS_cTBS_M/U
Arm Type
Experimental
Arm Description
In this group, they received iTBS on affected hemisphere after following cTBS at median/ulnar nerve on affected hand.
Arm Title
sham-rTMS+sham-rPMS
Arm Type
Sham Comparator
Arm Description
In this group, they received iTBS on affected hemisphere after following sham TBS stimulation at median/ulnar nerve on affected hand.
Arm Title
rTMS + optimal-rPMS
Arm Type
Experimental
Arm Description
In this group, patient received iTBS on affected hemisphere after following optimal repetitive peripheral magnetic stimulation(rPMS) on affected hand.
Arm Title
rTMS+ sham-rPMS
Arm Type
Experimental
Arm Description
In this group, patient received iTBS on affected hemisphere after following sham repetitive peripheral magnetic stimulation on affected hand.
Arm Title
sham-rTMS+optimal-rPMS
Arm Type
Sham Comparator
Arm Description
In this group, patient received sham iTBS on affected hemisphere after following optimal repetitive peripheral magnetic stimulation on affected hand.
Intervention Type
Device
Intervention Name(s)
rTMS+rPMS_iTBS_R
Intervention Description
Repetitive peripheral magnetic stimulation (rPMS) intermittent theta-burst stimulation pattern (iTBS) will intermittently give a 2 s train of iTBS every 10s repeated 2 times for a total of 40 times at radial nerve on the affected hand(low pulse: 1200 pulses in total). Then following Repetitive transcranial magnetic stimulation (rTMS) will intermittently give a 2 s train of iTBS every 10s repeated 2 times for a total of 40 times on affected hemisphere(low pulse: 1200 pulses in total).
Intervention Type
Device
Intervention Name(s)
rTMS+rPMS_cTBS_R
Intervention Description
Repetitive peripheral magnetic stimulation (rPMS) continuous burst stimulation pattern (cTBS) will intermittently give a cTBS treatment consists of a continuous train of TBS for 40 seconds repeated for 2 times at radial nerve on the affected hand(low pulse: 1200 pulses in total). Then following Repetitive transcranial magnetic stimulation (rTMS) will intermittently give a 2 s train of iTBS every 10s repeated 2 times for a total of 40 times on affected hemisphere(low pulse: 1200 pulses in total).
Intervention Type
Device
Intervention Name(s)
rTMS +sham-rPMS
Intervention Description
Repetitive peripheral magnetic stimulation (rPMS) sham burst stimulation pattern (sham TBS) will intermittently give a sham TBS treatment consists of a continuous train of TBS for 40 seconds at radial nerve on the affected hand(almost no pulse: 1200 pulses in total). Then following Repetitive transcranial magnetic stimulation (rTMS) will intermittently give a 2 s train of iTBS every 10s repeated 2 times for a total of 40 times on affected hemisphere(low pulse: 1200 pulses in total).
Intervention Type
Device
Intervention Name(s)
rTMS+rPMS_iTBS_M/U
Intervention Description
Repetitive peripheral magnetic stimulation (rPMS) intermittent theta-burst stimulation pattern (iTBS) will intermittently give a 2 s train of iTBS every 10s repeated 2 times for a total of 40 times at median nerve/nervus ulnaris on the affected hand(low pulse: 1200 pulses in total). Then following Repetitive transcranial magnetic stimulation (rTMS) will intermittently give a 2 s train of iTBS every 10s repeated 2 times for a total of 40 times on affected hemisphere(low pulse: 1200 pulses in total).
Intervention Type
Device
Intervention Name(s)
rTMS+rPMS_cTBS_M/U
Intervention Description
Repetitive peripheral magnetic stimulation (rPMS) continuous burst stimulation pattern (cTBS) will intermittently give a cTBS treatment consists of a continuous train of TBS for 40 seconds repeated for 2 times at median nerve/nervus ulnaris on the affected hand(low pulse: 1200 pulses in total). Then following Repetitive transcranial magnetic stimulation (rTMS) will intermittently give a 2 s train of iTBS every 10s repeated 2 times for a total of 40 times on affected hemisphere(low pulse: 1200 pulses in total).
Intervention Type
Device
Intervention Name(s)
sham-rTMS+sham-rPMS
Intervention Description
Repetitive peripheral magnetic stimulation (rPMS) sham burst stimulation pattern (sham TBS) will intermittently give a sham TBS treatment consists of a continuous train of TBS for 40 seconds at median nerve/nervus ulnaris on the affected hand(almost no pulse: 1200 pulses in total). Then following Repetitive transcranial magnetic stimulation (rTMS) will intermittently give a sham TBS treatment consists of a continuous train of TBS for 40 seconds on affected hemisphere(almost no pulse: 1200 pulses in total).
Intervention Type
Device
Intervention Name(s)
rTMS + optimal-rPMS
Intervention Description
The optimal Repetitive peripheral magnetic stimulation (rPMS) depend on previous results to give an iTBS or cTBS. Then following Repetitive transcranial magnetic stimulation (rTMS) will intermittently give a 2 s train of iTBS every 10s repeated 2 times for a total of 40 times on affected hemisphere(low pulse: 1200 pulses in total).
Intervention Type
Device
Intervention Name(s)
sham-rTMS+optimal-rPMS
Intervention Description
The optimal Repetitive peripheral magnetic stimulation (rPMS) depend on previous results to give an iTBS or cTBS. Then following Repetitive transcranial magnetic stimulation (rTMS) will intermittently give a sham TBS treatment consists of a continuous train of TBS for 40 seconds on affected hemisphere(almost no pulse: 1200 pulses in total).
Primary Outcome Measure Information:
Title
Change from baseline Motion analysis at after six weeks of treatment and three month
Description
All participants will be instructed to perform a series of upper-extremity tasks. The tasks include reaching and grasping. An 7-camera motion analysis system (Vicon system, 3-D Oxfort Metrics Ltd, Oxford, UK) is used in conjunction with a personal computer to capture the movement of markers placed on the participant's body; analog signals were collected simultaneously. Movements were recorded at 120 Hz and digitally low-pass filtered at 5 Hz using a second-order Butterworth filter. Reference markers are placed on the distal interphalangeal joints of the thumb and index finger, the styloid process of the ulna, proximal end of the second metacarpal, and the object.
Time Frame
baseline, after 6 weeks of treatment, 3 months
Title
Change from baseline Motor evoked potential at after six weeks of treatment and three month
Description
The comparison of baseline of Motor Evoked Potential for stroke after different therapy, including resting motor threshold (RMT), active motor thresholds (AMT), input-output curve (IO curve) and stationary period.
Time Frame
baseline, after 6 weeks of treatment, 3 months
Title
Change from baseline Myoton at after six weeks of treatment and three month
Description
The comparison of baseline of Myoton for stroke after different therapy, assessing the functional status of skeletal muscle.
Time Frame
baseline, after 6 weeks of treatment, 3 months
Title
Change from baseline Muscle strength at after six weeks of treatment and three month
Description
The comparison of baseline of Muscle strength for stroke after different therapy, including lateral pinch, palmar pinch, and tip pinch.
Time Frame
baseline, after 6 weeks of treatment, 3 months
Title
Change from baseline Brunnstrom stage at after six weeks of treatment and three month
Description
The Brunnstrom stage is used to classify the severity of stroke patient according to specific movement.
Time Frame
baseline, after 6 weeks of treatment, 3 months
Title
Change from baseline Fugl Meyer Assessment at after six weeks of treatment and three month
Description
The Fugl Meyer Assessment is used to measure upper and lower extremity motor , range of motion, sensation, pain and balance.
Time Frame
baseline, after 6 weeks of treatment, 3 months
Title
Change from baseline Modified Ashworth Scale at after six weeks of treatment and three month
Description
The Modified Ashworth Scale is used to measure the muscle tone of affected limb, for each item minimum value is 0 and maximum value is 4, higher scores mean a worse outcome.
Time Frame
baseline, after 6 weeks of treatment, 3 months
Secondary Outcome Measure Information:
Title
Change from baseline Action Research Arm Test at after six weeks of treatment and three month
Description
The Action Research Arm Test is used to measure bilateral gross manual and finger dexterity.
Time Frame
baseline, after 6 weeks of treatment, 3 months
Title
Change from baseline Box and Block Test at after six weeks of treatment and three month
Description
The Box and Block Test (BBT) measures unilateral gross manual dexterity.
Time Frame
baseline, after 6 weeks of treatment, 3 months
Title
Change from baseline Nine-Hole test at after six weeks of treatment and three month
Description
The Nine-Hole Peg Test (NHPT) is used to measure finger dexterity in patients with various neurological diagnoses.
Time Frame
baseline, after 6 weeks of treatment, 3 months
Title
Change from baseline Jebson Taylor Hand Function Test at after six weeks of treatment and three month
Description
The Jebson Taylor Hand Function Test (JTHFT) is used to assess a broad range of unilateral hand functions required for activities of daily living(ADLs).
Time Frame
baseline, after 6 weeks of treatment, 3 months
Title
Change from baseline Functional Independence Measure at after six weeks of treatment and three month
Description
The purpose of Functional Independence Measure(FIM) is to understand and track adult's life function performance, progress and goal achievement. There are three main areas: self-care, mobility, and cognition. The score is from 1 to 7 points, 1 is completely dependent, and 7 is completely independent.
Time Frame
baseline, after 6 weeks of treatment, 3 months
Title
Change from baseline Motor Activity Log at after six weeks of treatment and three month
Description
The Motor Activity Log(MAL) is used to measure the quality and quantity of a stroke patient when performing activities using the affected hand.
Time Frame
baseline, after 6 weeks of treatment, 3 months
Title
Change from baseline Wolf Motor Function Test at after six weeks of treatment and three month
Description
The Wolf Motor Function Test(WMFT) is used to measure unilateral motor quality and strength.
Time Frame
baseline, after 6 weeks of treatment, 3 months
Title
Change from baseline Nottingham Health Profile at after six weeks of treatment and three month
Description
The Nottingham Health Profile(NHP) is a questionnaire that assesses the quality of life associated with health. There are a total of 38 items, divided into six sub-items: mobility, social isolation, emotional response, pain, sleep and energy.
Time Frame
baseline, after 6 weeks of treatment, 3 months
Title
Change from baseline Stroke Impact Scale at after six weeks of treatment and three month
Description
The Stroke Impact Scale(SIS) is used to measure the influence of several aspects after stroke, for each item minimum value is 1 and maximum value is 5, higher scores mean a better outcome.
Time Frame
baseline, after 6 weeks of treatment, 3 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: first stoke and in stable phase age 20-80 years unilateral brain lesions with unilateral hemiplegia brain wave examination without epileptic waves Exclusion Criteria: brain stem or cerebellar stroke Patients with epilepsy Patients with aneurysm or cerebrovascular malformation Patients with mental illness Patients with degenerative diseases (such as neurodegenerative diseases) Patients with severe intelligence or language barriers (such as mental retardation or severe communication impairment) Patients with serious medical conditions (such as heart failure) Patients with acute disease (such as infection) Patients had metal implants in the body (such as cardiac rhythm or brain metal implants, metal clips for aneurysms) Patients had botox injection or surgery in the first half of the study pregnant woman or breastfeeding woman other obstacles (such as claustrophobia, obesity, etc.)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Chia-Ling Chen, MD, PhD
Phone
+886-3-3281200
Ext
8148
Email
clingchen@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Chia-Ling Chen
Organizational Affiliation
Chang Gung Memorial Hospital
Official's Role
Study Director
Facility Information:
Facility Name
Chang Gung Memoria Hospital
City
Taoyuan
ZIP/Postal Code
333
Country
Taiwan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Chia-Ling Chen, MD,PhD
Phone
+886-3-3281200
Ext
8147
Email
clingchen@gmail.com
First Name & Middle Initial & Last Name & Degree
Chia-Ling Chen, MD,PhD

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Efficacy of Integrated Therapy of rTMS and rPMS on Upper Limb Function in Patients With Stroke

We'll reach out to this number within 24 hrs